This is a working overview of Chromatographic purity, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-06-26. Anything still debated is marked as such rather than presented as settled.
In the fitness and bodybuilding literature, cardarine is frequently discussed as an endurance agent or fat-loss compound, although such claims are not supported by robust clinical evidence. Online descriptions often mix animal data, user anecdotes, and marketing language. Researchers who study PPARδ agonists distinguish between receptor activation in controlled experiments and unsupervised use of unverified products. The latter introduces unknown purity, dose, and interactions, making reported experiences difficult to interpret scientifically.
GW501516 acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in transcription of genes related to lipid handling and energy use. Activation of PPARδ can shift skeletal muscle toward greater fatty acid oxidation in animal models, which is one reason it drew interest for metabolic disease and exercise research. The exact downstream effects depend on tissue, species, dose, and duration. Human data are sparse, so many proposed benefits remain hypotheses rather than established clinical outcomes.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
| Property | Value | Notes |
|---|---|---|
| Solubility | Soluble in dimethyl sulfoxide and some organic solvents; practically insoluble in water | Solvent choice affects laboratory handling |
| Typical storage | -20 °C, desiccated, protected from light | Common condition for research samples |
| Analytical method | Liquid chromatography–tandem mass spectrometry (LC-MS/MS) | Used for identification and quantification in biological or product samples |
| Common synonyms | GW501516, GW-501516, GSK-516, Endurobol | Names found in research and anti-doping literature |
| Regulatory status | Unapproved therapeutic; prohibited in competitive sport | Status can vary by country and context |
Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.
Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.
Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
GW501516 acts as a ligand for PPAR delta, a nuclear receptor that regulates transcription of genes involved in fatty acid oxidation and energy use. Activation of this receptor in skeletal muscle shifts metabolism toward fat burning in animal models. The compound does not burn fat directly; it changes gene expression over hours to days. Researchers study it to understand metabolic flexibility and exercise adaptation. Effects observed in rodents are not automatically expected in humans.
In 2007, productive nanosystems were defined as functional nanoscale systems that make atomically-specified structures and devices under programmatic control, i.e., performing atomically precise manufacturing. As of 2015, such devices were only hypothetical, and productive nanosystems represented a more advanced approach among several to perform Atomically Precise Manufacturing. A workshop on Integrated Nanosystems for Atomically Precise Manufacturing was held by the Department of Energy in 2015. Present-day technologies are limited in various ways. Large atomically precise structures (that is, virtually defect-free) do not exist. Complex 3D nanoscale structures exist in the form of folded linear molecules such as DNA origami and proteins. As of 2026, it was also possible to build very small atomically precise structures using scanning probe microscopy to construct molecules such as FeCO and polyyne, or to perform hydrogen depassivation lithography. But it is not yet possible to combine components in a systematic way to build larger, more complex systems. Principles of physics and examples from nature both suggest that it will be possible to extend atomically precise fabrication to more complex products of larger size, involving a wider range of materials. An example of progress in this direction would be Christian Schafmeister's work on bis-peptides.
=== Compression === Some disorders as syndromes result from compression of a vein. These include a venous type of thoracic outlet syndrome, due to compression of a subclavian vein; nutcracker syndrome most usually due to compression of the left renal vein, and May–Thurner syndrome associated with compression of the iliac vein which can lead to iliofemoral DVT. Compression of the superior vena cava most usually by a malignant tumor can lead to superior vena cava syndrome.
Zearalenone (ZEN), also known as RAL and F-2 mycotoxin, is a potent estrogenic metabolite produced by some Fusarium and Gibberella species. Specifically, the Gibberella zeae, the fungal species where zearalenone was initially detected, in its asexual/anamorph stage is known as Fusarium graminearum. Several Fusarium species produce toxic substances of considerable concern to livestock and poultry producers, namely deoxynivalenol, T-2 toxin, HT-2 toxin, diacetoxyscirpenol (DAS) and zearalenone. Particularly, ZEN is produced by Fusarium graminearum, Fusarium culmorum, Fusarium cerealis, Fusarium equiseti, Fusarium verticillioides, and Fusarium incarnatum. Zearalenone is the primary toxin that binds to estrogen receptors, causing infertility, abortion or other breeding problems, especially in swine. Often, ZEN is detected together with deoxynivalenol in contaminated samples and its toxicity needs to be considered in combination with the presence of other toxins. Zearalenone is heat-stable and is found worldwide in a number of cereal crops, such as maize, barley, oats, wheat, rice, and sorghum. Its production increases when the climate is warm with air humidity at or above twenty percent. The environmental pH plays also a role in the toxin's production. When temperatures fall to 15 °C, alkaline soils still support ZEN production. At the preferred Fusarium temperature, which ranges between 25 °C and 30 °C, neutral pH results in the greatest toxin production.
=== Carboplatin === Pemetrexed is also recommended in combination with carboplatin and pembrolizumab for the first-line treatment of advanced non-small cell lung cancer. However, the relative efficacy or toxicity of pemetrexed-cisplatin versus pemetrexed-carboplatin has not been established beyond what is generally thought about cisplatin or carboplatin doublet drug therapy.
In electron ionization (EI), energetic electrons are produced by a hot cathode: a wire filament heated by running electric current through it, producing energetic electrons by thermionic emission. The electrons are then accelerated towards an anode. The voltage difference between the cathode and the anode determines the energy of the electron stream. Most organic compounds have ionization energy 8-15 eV, but empirically, the efficiency of ionization is too low unless the electron beam has an energy of 50-70 eV per electron. The spectral features, including fragmentation patterns, depend on the energy setting. Conventionally for EI, the electron energy is standardized to be exactly 70 eV. Consequently, if one wishes to compare their EI-MS results against standard databases, or produce results that can be added to standard databases, one must standardize their EI electron energy to 70 eV. EI accepts as input a stream of gas from the molecular leak. The gas stream crosses the electron stream perpendicularly. The collision ionizes the gas stream. The ion stream then is accerelated by a succession of electrodes. Typically an ion carrying 1 e would be accelerated to 1-10 keV. EI has many benefits for routine mass spectrometry of small organic molecules. It is cheap and robust, with reproducible spectrograms. Databases for EI spectrograms are widely available and covers many such molecules. EI is unsuited for large molecules, such as most biomolecules.
Sources: en.wikipedia.org
During the 19th century, following the discovery of the first tombs and artifacts in Egypt, egyptology became popular in Europe, especially in Victorian England. European aristocrats would occasionally entertain themselves by purchasing mummies, having them unwrapped, and holding observation sessions. The pioneer of this kind of entertainment in Britain was Thomas Pettigrew known as "Mummy" Pettigrew due to his work. Such unrolling sessions destroyed hundreds of mummies, because the exposure to the air caused them to disintegrate. While mummies were used in medicine, some researchers have brought into question these other uses such as making paper and paint, fueling locomotives and fertilizing land. The use of mummies as fuel for locomotives was documented by Mark Twain, likely humorously, but the truth of the story remains debatable. During the American Civil War, mummy-wrapping linens were said to have been used to manufacture paper. Evidence for the reality of these claims is still equivocal. Researcher Ben Radford reports that, in her book The Mummy Congress, Heather Pringle writes: "No mummy expert has ever been able to authenticate the story ... Twain seems to be the only published source – and a rather suspect one at that". Pringle also writes that there is no evidence for the "mummy paper" either. Radford says that many journalists have not done a good job with their research, and while it is true that mummies were often not shown respect in the 1800s, there is no evidence for this rumor.
Exercising regularly, as exercise increases cellular sugar uptake, which decreases excessive insulin release. Avoiding eating meals or snacks composed entirely of carbohydrates; simultaneously ingest fats and proteins, which have slower rates of absorption; Consistently choosing longer lasting, complex carbohydrates to prevent rapid blood-sugar dips in the event that one does consume a disproportionately large amount of carbohydrates with a meal; Monitoring any effects medication may have on symptoms. Low-carbohydrate diet and/or frequent small meals is the first treatment of this condition. The first important point is to add small meals at the middle of the morning and of the afternoon, when glycemia would start to decrease. If adequate composition of the meal is found, the fall in blood glucose is thus prevented. Patients should avoid rapidly absorbed sugars and thus avoid popular soft drinks rich in glucose or sucrose. They should also be cautious with drinks associating sugar and alcohol, mainly in the fasting state. As it is a short-term ailment, a sugar crash that was not caused by injecting too much insulin does not usually require medical intervention in most people. The most important factors to consider when addressing this issue are the composition and timing of foods. Acute (short-term) low blood sugar symptoms are best treated by consuming small amounts of sweet foods, so as to regain balance in the body's carbohydrate metabolism. Suggestions include sugary foods that are quickly digested, such as:
"It seems to me", Mellanby wrote to Florey, "that the line of work you are suggesting will be interesting and may prove to be of practical importance." Florey felt that far more would be required. On 1 November 1939, Henry M. "Dusty" Miller Jr from the Natural Sciences Division of the Rockefeller Foundation paid Florey a visit. Miller encouraged Florey to apply for funding from the foundation and supported his application. "The work proposed", Florey wrote in the application letter, "in addition to its theoretical importance, may have practical value for therapeutic purposes." His application was approved, with the foundation allocating US$5,000 (£1,250) per annum for five years. The Oxford team's first task was to obtain a sample of penicillin mould. This turned out to be easy. Georges Dreyer, Florey's predecessor, had obtained a sample of the mould in 1930 for his work on bacteriophages, viruses that infect bacteria. Dreyer had lost interest in penicillin when he discovered that it was not a bacteriophage, but he had continued to cultivate it. Dreyer had died in 1934, but Campbell-Renton had continued to culture the mould and was able to supply it to the Oxford team. The next task was to grow sufficient mould to extract enough penicillin for laboratory experiments. The mould was cultured on a surface of liquid Czapek-Dox medium. Over the course of a few days it formed a yellow gelatinous skin covered in green spores. Beneath this, the liquid became yellow and contained penicillin. The team determined that the maximum yield was achieved in ten to twenty days.
Chloramphenicol was first isolated from Streptomyces venezuelae in 1947 and in 1949 a team of scientists at Parke-Davis including Mildred Rebstock published their identification of the chemical structure and their synthesis. In 1972, Senator Ted Kennedy combined the two examples of the Tuskegee Syphilis Study and the 1958 Los Angeles Infant Chloramphenicol experiments as initial subjects of a Senate Subcommittee investigation into dangerous medical experimentation on human subjects. In 2007, the accumulation of reports associating aplastic anemia and blood dyscrasia with chloramphenicol eye drops led to the classification of "probable human carcinogen" according to World Health Organization criteria, based on the known published case reports and the spontaneous reports submitted to the National Registry of Drug-Induced Ocular Side Effects.
=== Frazier === On September 29, 2025, Seth Frazier, then 41 years old, pleaded guilty to four counts of first degree murder, one count of attempted first degree murder, six counts of assault with a deadly weapon with the intent to kill inflicting serious injury, and one count each of burning a public building, inciting riot, attempting escape and assault with a deadly weapon. As a result of his plea of guilt, Frazier was spared the death sentence and instead sentenced to four consecutive life sentences without parole for all four murder charges, plus 93 to 116 years for all the lesser offences he admitted to. Similarly to his co-defendants, Frazier was transferred into the federal prison system and is currently at USP Terre Haute.
Sources: en.wikipedia.org
It binds and activates PPARδ, a nuclear receptor that influences gene expression related to fatty acid metabolism and energy balance. This mechanism has been studied mainly in animals and cell models, not established as a safe human therapy.
No. It is not an anabolic-androgenic steroid; it is a synthetic PPARδ agonist. Because it is banned in sport, it is sometimes grouped with doping agents even though its chemical class differs from steroids.
Human data are limited and development was discontinued, so major effects and long-term risks are not well characterized. Some early studies examined metabolic markers, but they do not provide a basis for unsupervised use.
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.